Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2026-09-21 16:33:26 ET · period of report 2026-09-17 · accession 0001628280-26-062915 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 16:33 | 2026-09-17 | AMRX | BUCHI J KEVIN | Dir | G - Gift | $0.00 | -20.4K | 75.1K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-17 | G | D | 20,445 | $0.00 | 75,077 | D | — | — | (F1) On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust. (F1) On September 17th, the reporting person transferred 20,445 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust. |